Biotechnology Innovation Organization is a 501(c)(6) organization based in Washington, District of Columbia, registered in 1982, with $117,748,708 in FY2024 revenue. CharityIndex grades it A.
Revenue (FY2024)
$117.7M
▲ 3.5% vs prior year
Expenses (FY2024)
$100.0M
Net assets
$93.2M
Employees
180
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for Biotechnology Innovation Organization— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Biotechnology Innovation Organization: 11 mo reserves · +15% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Biotechnology Innovation Organization: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Biotechnology Innovation Organization: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Bio is the world's largest advocacy association representing approximately 1,000 member companies, state biotechnology groups, academic and research institutions, patient groups, and related organizations across the united states and in 30+ countries. bio is founded on the principle that policy must nurture innovation in the life sciences to overcome challenges in health care, agriculture, industry, and the environment. bio's efforts include advocacy and policy efforts focused on the innovative health of the sector along with convening events and offering other member services.
Services: bio's services include conferences and activities that bring advocacy accomplishments listed below:- safeguarded and advanced intellectual property protections, domestically and internationally.- fostered a dialogue about proactively advancing the socially responsible use of biotechnology.- promoted investment in government and academic research.- brought together industry stakeholders and investors for events ranging from the bio international convention to conferences for business development executives.the bio international convention attracts the most influential biotech and pharma attendees from 69 countries and 50 u.s. states, as well as the district of columbia and puerto rico and offers professional and business development opportunities. the net income from the convention supports our advocacy, public outreach, and other member service activities.the key elements of the bio international convention are educational programming, exhibition, the bio business forum, and networking events. these elements provide an opportunity for biotechnology and pharmaceutical companies, academic research institutions, and investors from around the world to learn about recent scientific and policy developments, and schedule one-on-one meetings to discuss potential business opportunities. the bio business forum at the convention hosts tens of thousands of partnering meetings among a few thousand companies, along with a couple hundred company presentations. the convention hosts hundreds of speakers, and over a thousand exhibitions with international, regional and state pavilions (and a number of product focus zones).beyond the convention, bio hosts or co-hosts a number of national and international conferences that provide venues for member and non-member companies to present new data, meet with fellow biotech companies, and attract funding from investors and other organizations.
Revenue grew from $65.6M (FY2013) to $117.7M (FY2024) across 11 reported years.
Financial snapshot
Operating margin
15.1%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$170.1M
Total liabilities
$76.9M
Net assets
$93.2M
Salaries & benefits
$42.0M
42% of expenses
Board members
86
85 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $117,748,708▲3.5% | $100,010,786▲9.1% | $93,170,801▲20.4% | $170,089,094▲8.6% | 990 |
| 2023 | $113,768,509▲10.3% | $91,630,164▲6.1% | $77,360,027▲52.4% | $156,639,347▲25.9% | 990 |
| 2022 | $103,185,175▲27.5% | $86,344,110▲7.9% | $50,764,197▲14.7% | $124,412,600▲9.5% | 990 |
| 2021 | $80,910,840▲4.7% | $80,058,118▼2.2% | $44,255,645▲1.2% | $113,666,319▲48.5% | 990 |
| 2020 | $77,279,517▼16.4% | $81,844,658▼14.9% | $43,742,474▼8.2% | $76,544,473▼9.3% | 990 |
| 2019 | $92,437,269▲5.9% | $96,191,552▲11.2% | $47,634,742▲13.5% | $84,368,104▲6.9% | 990 |
| 2018 | $87,310,431▲11.1% | $86,524,501▲10.5% | $41,971,397▼10.0% | $78,940,053▼2.6% | 990 |
| 2017 | $78,551,962▲2.1% | $78,317,024▼1.3% | $46,656,547▲17.3% | $81,025,145▲10.5% | 990 |
| 2016 | $76,915,410▲15.1% | $79,374,677▲20.0% | $39,782,111▼5.4% | $73,322,307▲7.7% | 990 |
| 2014 | $66,817,299▲1.9% | $66,132,964▼0.1% | $42,069,031▲3.9% | $68,085,013▲2.2% | 990 |
| 2013 | $65,580,696 | $66,176,549▲1.9% | $40,485,091▲4.1% | $66,638,973▲2.4% | 990 |
| 2012 | — | $64,927,338▲6.5% | $38,903,829▲2.2% | $65,054,922▼1.2% | 990 |
| 2011 | — | $60,961,422▲3.8% | $38,080,370▼2.2% | $65,857,637▲0.7% | 990 |
| 2010 | — | $58,750,175 | $38,949,018 | $65,414,013 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: John F Crowley — $2,747,033 (2.75% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| John F Crowley | President and Ceo | 40 | $2,747,033 |
| Rachel K King | Interim President and Ceo | 40 | $1,658,415 |
| Elizabeth Cartier Esham | Chief Science Officer | 40 | $1,012,398 |
| Stephen Jasko | Chief Business and Financial Officer | 40 | $808,510 |
| Richard Masters | Chief Public Affairs & Marketing Off | 40 | $744,710 |
| Peter Mchugh | Chief Legal Officer | 40 | $688,807 |
| Letonia D Fykes | Chief Events & Industry Programs Officer | 40 | $596,087 |
| John Murphy | Chief Policy Officer | 40 | $567,043 |
| Michelle Mcmurry-heath | Former President and Ceo | 40 | $264,130 |
| Alexander Hardy | Director (until October 2024) | 2 | — |
| Alexandria Forbes | Director | 2 | — |
| Amir Nashat | Director (until June 2024) | 2 | — |
| Andrew Obenshain | Director | 2 | — |
| Angela Carisa Ailloni | Director (until December 2024) | 2 | — |
| Anna Rath Until 32024 | Agriculture & Env Section Chair | 2 | — |
| Anthony Mancini | Director (until October 2024) | 2 | — |
| Barry P Flannelly | Director | 2 | — |
| Brad Bailey | Director | 2 | — |
| Bradford A Zakes | Treasurer | 2 | — |
| Bruce C Cozadd | Director | 2 | — |
| Contractor | Services | Paid |
|---|---|---|
| The Samantha Sault Agency LLC | Bespoke Editorial Content Services | $596,393 |
| Narrative Strategies | Strategic Communications Services | $492,650 |
| Keybridge Communications LLC | Public Relations and Issue Advocacy | $240,000 |
| Arent Fox Schiff LLP | Legislative and Regulatory Counseling | $222,523 |
| Health Management Associates Inc | Legislative and Regulatory Analysis | $205,000 |
10 grants to Biotechnology Innovation Organization totaling $4.5M, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Pharmaceutical Research and Manufacturers of America | General contribution | 2024 | $8,000 |
| Alzheimers Drug Discovery Foundation | Alzheimers research | 2023 | $73,700 |
| Pharmaceutical Research and Manufacturers of America | General contribution | 2021 | $2,814,000 |
| Pharmaceutical Research and Manufacturers of America | General contribution | 2020 | $122,000 |
| Pharmaceutical Research and Manufacturers of America | General contribution | 2019 | $1,065,000 |
| Pharmaceutical Research and Manufacturers of America | General contribution | 2018 | $85,000 |
| Pharmaceutical Research and Manufacturers of America | General contribution | 2017 | $82,500 |
| Pharmaceutical Research and Manufacturers of America | General contribution | 2016 | $126,386 |
| Pharmaceutical Research and Manufacturers of America | General contribution | 2015 | $45,000 |
| Pharmaceutical Research and Manufacturers of America | Contrib-general | 2014 | $73,513 |
76 grants totaling $2.0M in FY2024 — showing the 15 largest. All grants made by Biotechnology Innovation Organization →
| Recipient | Purpose | Amount |
|---|---|---|
| Republican Governors Association | Contribution | $195,000 |
| Bayh Dole Coalition | Contribution | $140,000 |
| Republican State Leadership Committee | Contribution | $130,000 |
| Democratic Governors Association | Contribution | $110,000 |
| National Health Council Inc | Contribution | $75,000 |
| National Governors Association Center For Best Practices | Contribution | $60,000 |
| Healthcare Ready | Contribution | $40,000 |
| Research America | Contribution | $40,000 |
| Chubb | Complimentary associate membership of bio bbs vendor | $32,272 |
| Airgas Healthcare | Complimentary associate membership of bio bbs vendor | $32,272 |
| Humboldt Storage & Moving | Complimentary associate membership of bio bbs vendor | $32,272 |
| Avantor | Complimentary associate membership of bio bbs vendor | $32,272 |
| American Laboratory Trading (alt) | Complimentary associate membership of bio bbs vendor | $32,272 |
| Brex | Complimentary associate membership of bio bbs vendor | $32,272 |
| Adp | Complimentary associate membership of bio bbs vendor | $32,272 |
Explore more
Data for Biotechnology Innovation Organization (EIN 52-1224577) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.